Previous close | 0.8000 |
Open | 0.7000 |
Bid | 0.5000 |
Ask | 0.9000 |
Strike | 5.00 |
Expiry date | 2024-07-19 |
Day's range | 0.6500 - 0.8000 |
Contract range | N/A |
Volume | |
Open interest | 10.33k |
Key Insights G1 Therapeutics will host its Annual General Meeting on 13th of June Total pay for CEO Jack Bailey...
RESEARCH TRIANGLE PARK, N.C., June 05, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for 4,650 shares of G1’s common stock and 2,400 restricted stock units (RSUs) to one hired employee under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Amended and Restated 2021 Plan”). These equity awards were granted as an inducement material to th
Every investor on earth makes bad calls sometimes. But really bad investments should be rare. So consider, for a...